A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
Clinical trial NCT03421431 · COMPLETED
Trial details
- NCT number
- NCT03421431
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-25
- Primary completion
- 2019-06-14
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.